Cancer Prevention Pharmaceuticals in Collaboration with the NCI and Vanderbilt University Medical Center Initiates Phase 2 Trial to Evaluate CPP-1X in Patients with High Risk of Gastric Cancer
Cancer Prevention Pharmaceuticals has launched a Phase 2 Clinical trial to evaluate the drug CPP-1x in patients with precancerous gastric lesions who... Read More
